Cargando…
Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity
This article aims to propose practical solutions that coordinate the conflicting interests between the global community and the pharmaceutical industry on the intellectual property (IP) waiver for COVID-19 vaccines and facilitate a more equitable vaccine supply chain in the post-COVID-19 world. We c...
Autores principales: | Park, Sung-Pil, Lee, Hye Jin, Yu, Yang, Lee, Eric Yong Joong, Park, Young Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689365/ https://www.ncbi.nlm.nih.gov/pubmed/38035734 http://dx.doi.org/10.1136/bmjgh-2023-013669 |
Ejemplares similares
-
It is not too late to achieve global covid-19 vaccine equity
por: Yamey, Gavin, et al.
Publicado: (2022) -
Vaccine access, equity and justice: COVID-19 vaccines and vaccination
por: Privor-Dumm, Lois, et al.
Publicado: (2023) -
Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
por: Sekalala, Sharifah, et al.
Publicado: (2021) -
Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
por: Okereke, Melody
Publicado: (2021) -
An intersectional human rights approach to prioritising access to COVID-19 vaccines
por: Sekalala, Sharifah, et al.
Publicado: (2021)